amikacin has been researched along with norfloxacin in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (38.30) | 18.7374 |
| 1990's | 2 (4.26) | 18.2507 |
| 2000's | 17 (36.17) | 29.6817 |
| 2010's | 10 (21.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Berçot, B; Nordmann, P; Poirel, L | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Dhamdhere, G; Krishnamoorthy, G; Zgurskaya, HI | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jia, CY | 1 |
| Bhan, MK; Khoshoo, V; Raj, P; Srivastava, R | 1 |
| Renneberg, J; Walder, M | 1 |
| de Boelpaepe, F; Demoulin, L; Dony, A; Leempoel, M | 1 |
| Amrani, R; Beklahia, C; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 2 |
| Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
| Bayer, AS; Hirano, L; Yih, J | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| de Moor, G; Lacroix, G; Mambour, A; Rossion, N; Schuyteneer, F; van der Auwera, P | 1 |
| Gulden, H; Kern, W; Kurrle, E; Vanek, E | 1 |
| Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Auzepy, P; Richard, C; Singlas, E; Sultan, E | 1 |
| Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
| Giacalone, G; Meoni, S; Monaci, E; Monaci, R | 1 |
| Brandimarte, C; Martino, P; Serra, P; Valente, B; Venditti, M | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
| Janicka, G; Kłyszejko, C; Sekowska, A; Szymankiewicz, M; Wojda, M; Wróblewski, M | 1 |
| Bal, AM; Ghadage, DP | 2 |
| Bansal, P; Bansal, R; Chaudhary, AK; Ghaiye, P; Gupta, V; Lather, A; Singh, R | 1 |
| Kogermann, K; Lippus, M; Lukk, E; Putrinš, M; Tenson, T; Varik, V | 1 |
| Andrade, JC; Datiane de Morais Oliveira-Tintino, C; de Araújo Delmondes, G; de Oliveira Almeida, W; de Queiroz Dias, D; Ferreira, FS; Gadelha Rocha, MF; Martins da Costa, JG; Melo Coutinho, HD; Pereira da Silva, AR; Romeu da Nóbrega Alves, R; Sales, DL; Tintino, SR | 1 |
1 review(s) available for amikacin and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
46 other study(ies) available for amikacin and norfloxacin
| Article | Year |
|---|---|
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Erythromycin; Escherichia coli; Glutathione; Kanamycin; Microbial Sensitivity Tests; Novobiocin; Spermidine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Drug resistance and floral distribution of Pseudomonas aeruginosa].
Topics: Amikacin; Burns; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Middle Aged; Norfloxacin; Pseudomonas aeruginosa; Serotyping | 1990 |
Salmonella typhimurium-associated severe protracted diarrhea in infants and young children.
Topics: Amikacin; Combined Modality Therapy; Diarrhea, Infantile; Failure to Thrive; Female; Fluid Therapy; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Prevalence; Salmonella Infections; Salmonella typhimurium | 1990 |
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Enterococcus faecalis; Escherichia coli; Female; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Norfloxacin; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1989 |
[Rectal ulcer infected by Mycobacterium fortuitum. Apropos of 4 cases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Female; Humans; Mycobacterium Infections; Norfloxacin; Rectal Diseases; Ulcer | 1989 |
[Enzymologic aspect of piperacillin combinations].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Enterobacter; Enzyme Induction; Hydrolysis; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa | 1986 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1988 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activity of enoxacin compared with norfloxacin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Calcium; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Kanamycin; Magnesium; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1988 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
Topics: Aged; Amikacin; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Norfloxacin; Pefloxacin; Resuscitation | 1987 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
[In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Norfloxacin | 1987 |
N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Thienamycins | 1985 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Netilmicin; Norfloxacin; Prevalence; Time Factors | 2002 |
Isolation of Salmonella enterica serotype Worthington from a splenic abscess in a patient with chronic myeloid leukemia.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Norfloxacin; Salmonella enterica; Salmonella Infections; Spleen | 2002 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors | 2002 |
In vitro evaluation of antimicrobial activity of Kutajghan vati - an Ayurvedic formulation.
Topics: Amikacin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Medicine, Ayurvedic; Norfloxacin; Plant Extracts | 2012 |
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Complement C3; Drug Resistance, Bacterial; Genetic Heterogeneity; Genotype; Humans; Microbial Sensitivity Tests; Microscopy, Fluorescence; Norfloxacin; Phenotype; Uropathogenic Escherichia coli | 2015 |
Body fat modulated activity of Gallus gallus domesticus Linnaeus (1758) and Meleagris gallopavo Linnaeus (1758) in association with antibiotics against bacteria of veterinary interest.
Topics: Adipose Tissue; Amikacin; Amoxicillin; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacteria; Chickens; Fatty Acids; Microbial Sensitivity Tests; Norfloxacin; Poultry Diseases; Turkeys | 2018 |